Patient-reported outcomes in trials of incretin-based therapies in patients with type 2 diabetes mellitus.
about
Mode of administration of dulaglutide: implications for treatment adherenceUnderstanding preferences for type 2 diabetes mellitus self-management support through a patient-centered approach: a 2-phase mixed-methods studyA bitter pill for type 2 diabetes? The activation of bitter taste receptor TAS2R38 can stimulate GLP-1 release from enteroendocrine L-cellsExenatide once weekly: opportunities in the primary care setting.Treatment satisfaction in people with type 2 diabetes mellitus treated with once-weekly dulaglutide: data from the AWARD-1 and AWARD-3 clinical trials.Liraglutide for treating type 1 diabetes.Attributes Influencing Insulin Pen Preference Among Caregivers and Patients With Diabetes Who Require Greater Than 20 Units of Mealtime Insulin.Dipeptidyl peptidase-4 inhibitors in type 2 diabetes therapy--focus on alogliptin.Patient-reported outcomes among patients using exenatide twice daily or insulin in clinical practice in six European countries: the CHOICE prospective observational study.The role of glucagon-like peptide-1 impairment in obesity and potential therapeutic implications.Peripheral targets in obesity treatment: a comprehensive update.Therapies for inter-relating diabetes and obesity - GLP-1 and obesity.Liraglutide for Type 2 diabetes and obesity: a 2015 update.Diurnal glucose exposure profiles of patients treated with lixisenatide before breakfast or the main meal of the day: An analysis using continuous glucose monitoring.Practical Considerations for the Use of Subcutaneous Treatment in the Management of Dyslipidaemia.Factors associated with health-related quality of life among overweight and obese Korean women.Treatment satisfaction with ITCA 650, a novel drug-device delivering continuous exenatide, versus twice-daily injections of exenatide in type 2 diabetics using metformin.The impact of weight loss on weight-related quality of life and health satisfaction: results from a trial comparing canagliflozin with sitagliptin in triple therapy among people with type 2 diabetes.Changes in weight loss-related quality of life among type 2 diabetes mellitus patients treated with dapagliflozin.Dapagliflozin improves treatment satisfaction in overweight patients with type 2 diabetes mellitus: a patient reported outcome study (PRO study).Use of Diabetes Treatment Satisfaction Questionnaire in Diabetes Care: Importance of Patient-Reported Outcomes.A health state utility valuation study to assess the impact of treatment mode of administration in Gaucher diseaseLonger acting GLP-1 receptor agonists and the potential for improved cardiovascular outcomes: a review of current literature
P2860
Q26744065-A1F2BF42-32D4-4D7B-8654-D1819CE59084Q27309115-A00C8DFA-31AB-4F15-80AB-6C5B871FE780Q28829204-32BBDA61-E000-4834-ADC6-199508076A8AQ30431639-06A3B4FB-5DB9-4962-9C1B-08168AC38C91Q30975622-5E76D8C7-8093-4EB2-BA60-8742515E5E99Q35939660-0CC38C91-7262-4505-A893-555F981E9D8BQ37054680-3986C73A-A2E4-4711-83CF-8DC434486F55Q37195882-D27FB1AF-1045-44FB-9356-492C127CEE95Q37509903-25CFDC07-EF58-49C9-A2B4-06380DF85337Q38101677-CC3868F4-9B36-4AF5-A632-55BD597EDCE9Q38194649-9904E87E-83A4-4BB1-8D50-CC1EE84CCDDAQ38254745-2B739E77-0750-40C2-8528-BF6FC2AC8347Q38536672-5F7B2B83-B0B1-47E8-B6CB-610E2D2D1180Q39054666-43A8E819-0096-4D31-BA0B-2DCD10692BB0Q39440767-FC52F0F2-9494-4100-9892-425FDE542539Q41366616-3904F304-69FE-4BFA-83FB-BB90C62AF082Q46519581-A815FBE8-8DBC-47C1-BCE7-811851199CC2Q46776718-AD608838-11B1-419C-91EB-180EAE2D2D4AQ47187857-3CACEB35-58F5-47C8-9E29-7F091E22BDAFQ51744128-655BE36D-4B8F-4C0A-938F-62FB927E5EE9Q55280514-E82C1910-AF9E-4354-9F72-49E9A8AA2311Q57159147-FF82BC4C-7D66-4797-9E02-0A5E697BE37DQ57406244-D5B3F457-E8DA-4416-95EB-872F6D48B1E6
P2860
Patient-reported outcomes in trials of incretin-based therapies in patients with type 2 diabetes mellitus.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Patient-reported outcomes in t ...... with type 2 diabetes mellitus.
@en
Patient-reported outcomes in t ...... with type 2 diabetes mellitus.
@nl
type
label
Patient-reported outcomes in t ...... with type 2 diabetes mellitus.
@en
Patient-reported outcomes in t ...... with type 2 diabetes mellitus.
@nl
prefLabel
Patient-reported outcomes in t ...... with type 2 diabetes mellitus.
@en
Patient-reported outcomes in t ...... with type 2 diabetes mellitus.
@nl
P2860
P1476
Patient-reported outcomes in t ...... with type 2 diabetes mellitus.
@en
P2860
P304
P356
10.1111/J.1463-1326.2012.01595.X
P577
2012-04-17T00:00:00Z